NCT01295164

Brief Summary

The instrument that will be used in the study is the Murcia monocular Adaptive Optics Visual simulator (AOVIS-I). The system provides an objective characterization of the optical quality of the patient's eye by application of wave-front sensing technology. The optical condition of every eye is represented by its wave aberration. This characterization overcomes the current description based only in refractive errors. This provides an accurate description of the optics of the eye based on the assessment of the whole set of ocular aberrations. The particular wave-front sensor is of a Hartmann-Shack type. One characteristics of this wave-front sensor is its high dynamic range allowing measuring highly aberrated eyes, such as patients with keratoconus.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2011

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 9, 2011

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 14, 2011

Completed
8 months until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

March 3, 2017

Status Verified

March 1, 2017

Enrollment Period

1.1 years

First QC Date

February 9, 2011

Last Update Submit

March 1, 2017

Conditions

Keywords

keratoconus, wave-front sensing technology, aberrometer

Outcome Measures

Primary Outcomes (1)

  • The primary outcome of the study is to evaluate the AOVIS-I and its wave-front sensor with high dynamic range for measuring high-order aberrations in patients with late stages (3 and 4) of keratoconus

    at the 1st day

Secondary Outcomes (2)

  • To evaluate the reliability of the measures in early stages (1 and 2) of keratoconus as compared with a "classic aberrometer".

    at the 1st day

  • To describe the measures obtained in advanced stages (3 and 4) of keratoconus.

    at the 1st day

Study Arms (4)

Group 1

ACTIVE COMPARATOR

Measurement of aberrations in patients with keratoconus of grade 1

Device: classic aberrometer and aberrometer AOVIS-1

Group 2

ACTIVE COMPARATOR

patients with keratoconus of grade 2

Device: classic aberrometer and aberrometer AOVIS-1

Group 3

EXPERIMENTAL

patients with keratoconus of grade 3

Device: Aberrometer AOVIS-I

Group 4

EXPERIMENTAL

patients with keratoconus of grade 4

Device: Aberrometer AOVIS-I

Interventions

Measurement of aberrations in early stages (1 and 2) of keratoconus as compared aberrometer AOVIS-1 with a "classic aberrometer".

Group 1Group 2

Measurement of aberrations in high stages (3 and 4) of keratoconus. Objective characterization of the optical quality of the patient eye by application of wave-front sensing technology in late stage keratoconus The complete procedure in one patient takes less than 5 minutes in only one consultation and is completely non invasive. The optical measurements only involve the use of low power infrared laser

Group 3Group 4

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • to be able to understand an information and give a consent
  • patients over 18
  • patients with keratoconus
  • affiliated to medical insurance.

You may not qualify if:

  • non keratoconus patients
  • patients under 18
  • pregnant women or nursing mothers
  • ocular infection
  • keratitis
  • restless patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hopstial Toulouse

Toulouse, 31000, France

Location

MeSH Terms

Conditions

Keratoconus

Condition Hierarchy (Ancestors)

Corneal DiseasesEye Diseases

Study Officials

  • Francois Malecaze, MD

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 9, 2011

First Posted

February 14, 2011

Study Start

October 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

March 3, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations